Contents
Working directories
1 | # ganttproject installation |
It took me four hours for update in X1.
Hexo
TOC
免密上传
[[Hexo#Password free upload|免密上传]]
1 | sudo hexo init |
- Connecting to GitHub with SSH - GitHub Docs
- hotliu/hotliu.github.io: Hexo Blog
- SSH and GPG keys
- 新增 SSH 密钥到 GitHub 帐户 - GitHub Docs
- 新增 SSH 密钥到 GitHub 帐户 - GitHub Docs
Proteomics
B95-8_Nrf2 Project
- 001_EBV_blocks_the_autophagic_flux_n_appropriates_the_autophagic_machinery_to_enhance_viral_replication.pdf
- 002_EBV_reduces_autophagy_intracellular_ROS_n_mitochondria_to_impair_monocyte_survival_n_differentiation.pdf
- 002_Nrf2_Is_a_Direct_PERK_Substrate_n_Effector_of_PERK-Dependent_Cell_Survival.pdf
- 003_Regulation_of_Autophagic_Activation_by_Rta_of_EBV_via_the_Extracellular_Signal-Regulated_Kinase_Pathway.pdf
- 004_p62-mediated_Selective_autophagy_endows_virus-transformed_cells_with_insusceptibility_to_DNA_damage_under_oxidative_stress.pdf
- 005_Stimulus_duration_n_response_time_independently_influence_the_kinetics_of_lytic_cycle_reactivation_of_EBV.pdf
- 006_LMP1_n_2A_Induce_the_Expression_of_Nrf2_Through_Akt_Signaling_Pathway_in_EBV-Transformed_B_Cells.pdf
- 007_Bortezomib_promotes_KHSV_n_EBV_lytic_cycle_by_activating_JNK_n_autophagy.pdf
- 008_EBV_n_KSHV_Infection_Dysregulates_Autophagy_to_Optimize_Viral_Replication_Prevent_Immune_Recognition_n_Promote_Tumorigenesis.pdf
- 009_PKC_theta_n_p38_MAPK_activate_the_EBV_lytic_cycle_through_autophagy_induction.pdf
- 010_Protein_Kinase_C-Independent_Activation_of_the_EBV_Lytic_Cycle.pdf
- 011_Regulation_of_the_ARE_by_PKC-mediated_phosphorylation_of_Nrf2.pdf
- 012_Stress-sensing_mechanisms_n_the_physiological_roles_of_the_Keap1–Nrf2_system_during_cellular_stress.pdf
- 013_NRF2_in_regulating_cancer_metabolism.pdf
- 014_NRF2_n_the_Hallmarks_of_Cancer.pdf
- 015_NRF2_addiction_in_cancer_cells.pdf
- 016_The_Dual_Roles_of_NRF2_in_Cancer.pdf
- 017_The_Nrf2_Activator_tBHQ_Differentially_Affects_Early_Events.pdf
- 018_Stabilization_of_Nrf2_by_tBHQ.pdf
- 019_The_B95-8_Isolate_of_EBV_Arose_from_an_Isolate_with_a_Standard_Genome.pdf
- 020_Transcription_n_DNA_sequence_of_the_BamHI_L_fragment_of_B95-8_EBV.pdf
- 021_Growth_of_B95-8_cells_n_expression_of_EBV_lytic_phase_in_serum-free_medium.pdf
- 022_Growth_of_B95-8_Cell_line_n_production_of_human_EBV_virus_2010.pdf
- 023_Growth_of_B95-8_Cell_line_n_production_of_human_EBV_virus_2016.pdf
- 024_EBV_Turns_50.pdf
- 025_The_transforming_prototype_of_EBV_B95-8_is_also_a_lytic_virus.pdf
- 026_Optimizing_osmotic_pressure_removes_EBV_particles_from_B95-8_host_cells_while_maintaining_normal_activity.pdf
- 027_Enhancement_of_spontaneous_VCA_n_EA_induction_in_B95-8_cells_n_EA_induction_in_Raji_cells.pdf
- 028_Molecular_cytogenetic_characterization_of_the_EBV-producing_cell_line_B95-8_by_chromosome_sorting_n_painting.pdf
- 029_Release_of_Infectious_EBV_by_Transformed_Marmoset_Leukocytes.pdf
- 030_EBV_Transformation_Cytopathic_Changes_n_Viral_Antigens_in_Squirrel_Monkey_n_Marmoset_Leukocytes.pdf
- 031_EBV_latent_genes.pdf
- 032_Encyclopedia_of_EBV-Encoded_Lytic_Genes_An_Update.pdf
- 033_TPA_Oncogenic_KRAS_confers_chemoresistance_by_upregulating_NRF2.pdf
- 034_NaB_Activation_of_Lytic_EBV_Infection_by_Radiation_n_NaB_in_Vitro_n_in_Vivo.pdf
- 035_NaB_AMPK_synergizes_with_the_combined_treatment_of_ACA_n_NaB_to_upregulate_phase_II_detoxifying_enzyme_activities.pdf
- 036_NaB_Butyrate-producing_probiotics_reduce_nonalcoholic_fatty_liver_disease_progression_in_rats.pdf
- 037_NaB_NaB_activates_NRF2_to_ameliorate_diabetic_nephropathy_possibly_via_inhibition_of_HDAC.pdf
- 038_NaB_NaB_improves_antioxidant_stability_in_sub-acute_ruminal_acidosis_in_dairy_goats.pdf
- 039_NaB_NaB_protects_against_high-fat_diet-induced_oxidative_stress_in_rat_liver_by_promoting_expression_of_Nrf2.pdf
- 040_BZ_induction_of_CEBPβ_mediates_EBV_lytic_activation_in_Burkitt_lymphoma.pdf
- 041_NaB_The_enhancement_of_phase_2_enzyme_activities_by_NaB_in_normal_intestinal_epithelial_cells_is_associated_with_Nrf2_n_p53.pdf
- 042_NaB_NaB_attenuates_diabetes-induced_aortic_endothelial_dysfunction_via_P300-mediated_transcriptional_activation_of_Nrf2.pdf
- 043_BZ_High_basal_nuclear_levels_of_Nrf2_in_acute_myeloid_leukemia_reduces_sensitivity_to_proteasome_inhibitors.pdf
- 044_BZ_HO-1_up-regulation_A_key_point_in_high-risk_neuroblastoma_resistance.pdf
- 046_BZ_Treatment-induced_oxidative_stress_n_cellular_antioxidant_capacity_determine_response_to_bortezomib.pdf
- 047_BZ_Bortezomib_induces_HO-1_expression_in_multiple_myeloma.pdf
- 048_TG_Regulation_of_Nrf2_by_XBP1_in_Retinal_Pigment_Epithelium.pdf
- 049_TG_Transcriptional_Regulation_of_ATF4_under_Oxidative_Stress.pdf
- 050_KSHV_Induces_Nrf2_Activation_in_Latently_Infected_Endothelial_Cells_through_SQSTM1_Phosphorylation_n_Interaction_with_Keap1.pdf
- 051_KSHV_Cytotoxic_Drugs_Activate_KSHV_Lytic_Cycle_in_Latently_Infected_PEL_Cells_by_Inducing_a_Moderate_ROS_Increase_Controlled_by_HSF1_NRF2_n_p62.pdf
- 052_KSHV_Activated_Nrf2_Interacts_with_KSHV_Latency_Protein_LANA-1_n_Host_Protein_KAP1_To_Mediate_Global_Lytic_Gene_Repression.pdf
- 053_TG_Promising_therapeutic_effect_of_TG_nanoparticles_on_chronic_kidney_disease_through_the_activation_of_Nrf2_n_FoxO1.pdf
- 054_Mutant_p53_Stabilized_by_Its_Interplay_with_HSP90_Activates_a_Positive_Feed-Back_Loop_Between_NRF2_n_p62.pdf
- 055_Constitutive_autophagy_contributes_to_resistance_to_TP53-mediated_apoptosis_in_EBV-positive_latency_III.pdf
- 056_Monitoring_Keap1–Nrf2_interactions_in_single_live_cells.pdf
- 057_Role_of_p62_SQSTM1_beyond_autophagy.pdf
- 058_Contribution_of_NAD_P_H_quinone_oxidoreductase_1_to_protection_against_carcinogenesis_n_regulation_of_its_gene_by_Nrf2.pdf
- 059_When_autophagy_meets_cancer_through_p62_SQSTM1.pdf
- 060_The_Role_of_the_Selective_Adaptor_p62_n_Ubiquitin-LikeProteins_in_Autophagy.pdf
- 061_Small_Maf_proteins_History_structure_n_function.pdf
- 062_Crosstalk_between_Nrf2_n_Notch_signaling.pdf
- 063_Regulation_of_cell_proliferation_n_migration_by_p62_through_stabilization_of_Twist1.pdf
- 064_Nrf2_negatively_regulates_STING_indicating_a_link_between_antiviral_sensing_n_metabolic_reprogramming.pdf
- 065_Mutant_p53_n_Cellular_Stress_Pathways_A_Criminal_Alliance_That_Promotes_Cancer_Progression.pdf
- 066_Overview_of_Nrf2_as_Therapeutic_Target_in_Epilepsy.pdf
- 067_P62_An_emerging_oncotarget_for_osteolytic_metastas.pdf
- 068_Genetic_Variations_n_mRNA_Expression_of_NRF2_in_Parkinsons_Disease.pdf
- 069_Phorbol_Ester-dependent_Activation_of_Peroxiredoxin_I_Gene_Expression_TPA.pdf
- 070_Cellular_Differentiation_Regulator_BLIMP1_Induces_EBV_Lytic_Reactivation_in_Epithelial_n_B_Cells.pdf
- 071_Inactivation_of_NF-kB_by_EBV_BZLF-1-Encoded_ZEBRA_Protein_in_Human_T_Cells.pdf
- 072_EBNA-1_induces_expression_of_the_cellular_microRNA_hsa-miR-127_n_impairing_B-cell_differentiation.pdf
- 073_Detection_of_IgG_n_IgA_Ab_to_EBV_membrane_Ag_in_sera_from_patients_with_NPC_n_from_normal_individuals.pdf
- 074_Expression_of_EBV_antibody_EA-IgA_Rta-IgG_n_VCA-IgA_n_SA_in_serum.pdf
- 075_Differentiation-Dependent_KLF4_Expression_Promotes_Lytic_EBV_Infection_in_Epithelial_Cells.pdf
- 076_EBV_infection_induces_aberrant_TLR_activation_pathway_n_fibroblast-myofibroblast_conversion_in_scleroderma.pdf
- 077_quercitrin_Inhibition_of_AP-1_n_MAPK_signaling_n_activation_of_Nrf2_ARE_pathway_by_quercitrin.pdf
- 078_Quercetin_Interrupts_the_Positive_Feedback_Loop_Between_STAT3_n_IL-6_Promotes_Autophagy_n_Reduces_ROS.pdf
- 079_Combination_of_betulinic_acid_n_chidamide_synergistically_inhibits_EBV_replication_through_over-generation_of_ROS.pdf
- 080_Chloroquine_Combination_Therapy_with_a_PI3KmTOR_Dual_Inhibitor_n_Chloroquine_Enhances_Synergistic_Apoptotic_Cell_Death_in_EBV-Infected.pdf
- 081_Chloroquine_triggers_EBV_replication_through_phosphorylation_of_KAP1_TRIM28_in_Burkitt_lymphoma_cells.pdf
- 082_Deletion_of_EBV_BFLF2_leads_to_impaired_viral_DNA_packaging_n_primary_egress_as_well_as_to_the_production_of_defective_viral_particles.pdf
- 083_EBV_LF2_Protein_Regulates_Viral_Replication_by_Altering_Rta_Subcellular_Localization.pdf
- 084_RNAs_in_EBV_control_early_steps_of_infection.pdf
- 085_The_EBV_EBNA-2_Gene_in_Oral_Hairy_Leukoplakia.pdf
- 086_TPA_Inhibition_of_Activator_Protein-1_NF-κB_n_MAPKs_n_Induction_of_Phase_2_Detoxifying_Enzyme_Activity.pdf
- 087_Atypical_PKC_mediates_activation_of_Nrf2_in_response_to_oxidative_stress.pdf
- 088_Latent_n_lytic_cycle_promoters_of_EBV.pdf
- 089_Switches_of_Oncogenic_Human_Gammaherpesviruses1.pdf
- 090_TPA_induction_of_EBV_early_antigens_in_Raji_cells_is_blocked_by_selective_PKC_inhibitors.pdf
- 091_Bortezomib-induced_EBV_n_KSHV_lytic_gene_expression_oncolytic_strategies.pdf
- 092_bZIP_proteins_of_human_gammaherpesviruses.pdf
- 093_Regulation_of_cellular_n_viral_protein_expression_by_the_EBV_transcriptional_regulator_Zta_Implications_for_therapy_of_EBV.pdf
- 094_Structural_basis_of_lytic_cycle_activation_by_the_EBV_ZEBRA_protein.pdf
- 095_TPA_induces_EBV_reactivation_via_NF-kappaB_n_AP-1_as_regulated_by_PKC_n_mitogen-activated_protein_kinase.pdf
- 096_Phosphorylation_of_Nrf2_at_Ser-40_by_PKC_regulates_ARE-mediated_transcription.pdf
- 097_Induction_of_EBV_lytic_cycle_in_vitro_causes_oxidative_stress_in_lymphoblastoid_B_cell_lines.pdf
- 098_Induction_of_EBV_Lytic_Cycle_in_Vitro_Causes_Lipid_Peroxidation_Protein_Oxidation_n_DNA_Damage_in_Lymphoblastoid_B_Cell_Lines.pdf
- 099_Reactive_oxygen_species_production_n_antioxidant_enzyme_expression_after_EBV_lytic_cycle_induction_in_Raji_cell_line.pdf
- 102_EBV_induces_an_oxidative_stress_during_the_early_stages_of_infection_in_B_lymphocytes_epithelial_n_lymphoblastoid_cell_lines.pdf
- 103_The_role_of_oxidative_stress_in_EBV_lytic_reactivation_radioresistance_n_the_potential_preventive_n_therapeutic_implications.pdf
- 104_Transcription_of_the_EBV_lytic_cycle_activator_BZLF-1_during_oxidative_stress_induction.pdf
- 105_Silver_nanoparticles_selectively_induce_human_oncogenic_γ-herpesvirus-related_cancer_cell_death.pdf
- 106_Reactive_oxygen_species_drive_herpes_simplex_virus_HSV_-1-induced_proinflammatory_cytokine_production_by_murine_microglia.pdf
- 107_Reactive_oxygen_signaling_n_MAPK_activation_distinguish_EBV-positive_versus_EBV-negative_Burkitt’s_lymphoma.pdf
- 108_Combination_of_betulinic_acid_n_chidamide_synergistically_inhibits_EBV_replication_through_over-generation_of_ROS.pdf
- 109_Bortezomib_n_SAHA_synergistically_induce_ROS-driven_caspase-dependent_apoptosis_of_NPC_n_block_replication_of_EBV.pdf
- 110_Calcium_mobilization_is_responsible_for_Thapsigargin_induced_EBV_lytic_reactivation_in_in_vitro_immortalized_lymphoblstoid_cell_lines.pdf
- 111_EBV_post-transplant_lymphoproliferative_disease_n_virus-specific_therapy-pharmacological_re-activation_of_viral_target_genes_with_arginine_butyrate.pdf
- 112_EBV_reactivation_n_therapeutic_inhibitors.pdf
- 113_EBV-targeted_therapy_in_nasopharyngeal_carcinoma.pdf
- 114_Contribution_of_the_KSHV_n_EBV_lytic_cycles_to_tumourigenesis.pdf
- 115_EBV_lytic_reactivation_regulation_n_its_pathogenic_role_in_carcinogenesis.pdf
- 116_Detection_n_characterization_of_EBV_in_clinical_specimens.pdf
- 117_EBV_Lytic_Cycle_Reactivation.pdf
- 118_Lytic_cycle_switches_of_oncogenic_human_gammaherpesviruses.pdf
- 119_Regulation_n_dysregulation_of_EBV_latency.pdf
- 120_EBV-driven_B-cell_lymphoproliferative_disorders.pdf
- 121_The_EBV_in_T_Cell_n_NK_Cell_Lymphomas-Time_for_a_Reassessment.pdf
- 122_Endoplasmic_reticulum_stress_causes_EBV_lytic_replication.pdf
- 123_p62_SQSTM1-Jack_of_All_Trades_in_Health_n_Cancer.pdf
- 124_Activation_of_SQSTM1-Keap1-Nrf2_Pathway_in_Cancer.pdf
- 125_Canonical_n_non-canonical_mechanisms_of_Nrf2_activation.pdf
- 126_Upregulation_of_STAT3_marks_Burkitt_lymphoma_cells_refractory_to_EBV_lytic_cycle_induction_by_HDAC_inhibitors.pdf
- 127_Valproic_Acid_Antagonizes_the_Capacity_of_Other_HDAC_Inhibitors_To_Activate_the_EBV_Lytic_Cycle.pdf
- 128_Nitric_Oxide_Down-Regulates_EBV_Reactivation_in_Epithelial_Cell_Lines.pdf
- 129_EBV_lytic_transactivator_Zta_enhances_chemotactic_activity_through_induction_of_interleukin-8_in_NPC_cells.pdf
- 130_Changes_in_the_nasopharyngeal_carcinoma_nuclear_proteome_induced_by_the_EBNA1_reveal_potential_roles_in_metastasis_n_oxidative_stress.pdf
- 131_0810619106SI.pdf
- 131_The_EBV_nuclear_antigen-1_promotes_genomic_instability_via_induction_of_ROS.pdf
- 132_The_EBV_nuclear_antigen-1_promotes_telomere_dysfunction_via_induction_of_oxidative_stress.pdf
- 133_EBV-encoded_EBNA1_regulates_cell_viability_by_modulating_miR34a-NOX2-ROS_signaling_in_gastric_cancer_cells.pdf
- 134_Crosstalk_between_the_mTOR_n_Nrf2-ARE_signaling_pathways_as_a_target_in_the_improvement_of_long-term_potentiation.pdf
- 135_Niclosamide_inhibits_lytic_replication_of_EBV_by_disrupting_mTOR_activation2.pdf
- 135_Niclosamide_inhibits_lytic_replication_of_EBV_by_disrupting_mTOR_activation.pdf
- 136_Inhibition_of_mTORC1_inhibits_lytic_replication_of_EBV_in_a_cell-type_specific_manner.pdf
- 137_Nrf2_Transcription_Factor_Can_Directly_Regulate_mTOR.pdf
- 138_Chloroquine_inhibits_lytic_replication_of_KSHV_by_disrupting_mTOR_n_p38-MAPK_activation.pdf
- 139_mTOR_inhibitors_induce_cell-cycle_arrest_n_inhibit_tumor_growth_in_EBV-associated_T_n_natural_killer_cell_lymphoma_cells.pdf
- 140_mTOR-Mediated_Antioxidant_Activation_in_Solid_Tumor_Radioresistance.pdf
- 141_Transcriptional_regulation_of_the_stress_response_by_mTOR.pdf
- 143_Molecular_mechanisms_of_mTOR_regulation_by_stress.pdf
- 144_Mazes_of_Nrf2_Regulation.pdf
- 145_Global_downstream_pathway_analysis_reveals_a_dependence_of_oncogenic_Nrf2_mutation_on_the_mTOR_growth_signaling_pathway.pdf
- 146_Inhibition_of_PI3KAKTmTOR_axis_disrupts_oxidative_stress-mediated_survival_of_melanoma_cells.pdf
- 147_Insights_for_Oxidative_Stress_n_mTOR_Signaling_in_Myocardial_Ischemia-Reperfusion_Injury_under_Diabetes.pdf
- 148_ROS_signaling_under_metabolic_stress_cross-talk_between_AMPK_n_AKT_pathway.pdf
- 149_Expression_of_EBV_latent_antigens_mTOR_n_tumor_suppression_genes_in_EBV-positive_smooth_muscle_tumors.pdf
- 150_EBV_encoded_LMP1_regulates_mTOR_signaling_pathway_genes_which_predict_poor_prognosis_of_nasopharyngeal_carcinoma.pdf
- 151_Latent_membrane_protein_1_of_EBV_activates_phosphatidylinositol_3-kinase_to_induce_production_of_IL-10.pdf
- 152_Modulation_of_the_cell_growth_regulator_mTOR_by_EBV_LMP2A.pdf
- 153_Oncogene-induced_Nrf2_transcription_promotes_ROS_detoxification_n_tumorigenesis_NIHMS313089-supplement-1.pdf
- 153_Oncogene-induced_Nrf2_transcription_promotes_ROS_detoxification_n_tumorigenesis.pdf
- 154_MNNG_induces_n_cooperates_with_TB_to_enhance_EBV_reactivation_n_genome_instability_in_nasopharyngeal_carcinoma_cells.pdf
- 155_The_Keap1-Nrf2-antioxidant_response_element_pathway-a_review_of_its_regulation_by_melatonin_n_the_proteasome.pdf
- 156_mTOR_signaling_pathway_n_mTOR_inhibitors_in_cancer_progress_n_challenges.pdf
- 157_HDACi_chidamide_induces_growth_inhibition_n_apoptosis_in_NK-T_lymphoma_cells_through_ATM-Chk2-p53-p21_signalling_pathway.pdf
- 158_Therapies_based_on_targeting_EBV_lytic_replication_for_EBV-associated_malignancies.pdf
- 159_Activation_of_p62-Keap1-Nrf2_Pathway_in_Cancer.pdf
- 160_p62_as_a_therapeutic_target_for_tumor.pdf
- 161_p62_is_a_key_regulator_of_nutrient_sensing_in_the_mTORC1_pathway.pdf
- 162_p62-related_pathways_as_therapeutic_targets_in_hepatocellular_carcinoma.pdf
- 163_Autophagy_n_its_role_in_gastric_cancer.pdf
- 164_Autophagy_pathway_Cellular_n_molecular_mechanisms.pdf
- 165_Role_of_p62_in_liver_physiology_n_pathogenesis.pdf
- 166_Targeting_autophagy_in_cancer.pdf
- 167_Autophagy_n_disease-unanswered_questions.pdf
- 168_Autophagy_in_cancer-moving_from_understanding_mechanism_to_improving_therapy_responses_in_patients.pdf
- 169_Guidelines_for_the_use_n_interpretation_of_assays_for_monitoring_autophagy_3rd_edition.pdf
- 170_Targeting_autophagy_in_cancer_2018.pdf
- 171_Cisplatin_induces_autophagy_to_enhance_hepatitis_B_virus_replication_via_activation_of_ROS_JNK_n_inhibition_of_the_AktmTOR_pathway.pdf
- 172_Autophagy_during_viral_infection—_a_double-edged_sword.pdf
- 173_KSHV_infection_inhibits_macrophage_formation_n_survival_by_counteracting_M-CSF-induced_increase_of_ROS_c-JNK_phosphorylation_n_autophagy.pdf
- 174_FGF9-induced_changes_in_cellular_redox_status_n_HO-1_upregulation_are_FGFR-dependent_n_proceed_through_both_ERK_n_AKT_to_induce_CREB_n_Nrf2_activation.pdf
- 175_Essential_roles_of_the_PI3_kinase-Akt_pathway_in_regulating_Nrf2-dependent_antioxidant_functions_in_the_RPE.pdf
- 176_Maltol_Slows_d-Galactose-Induced_Brain_Aging_Process_by_Damping_the_Nrf2HO-1-Mediated_Oxidative_Stress_in_Mice.pdf
- 177_EBV_Associated_Lymphomas_n_Epithelia_Cancers_in_Humans.pdf
- 178_Cytolytic_virus_activation_therapy_for_EBV-driven_tumors.pdf
- 179_Activation_of_lytic_cycle_of_EBV_by_suberoylanilide_hydroxamic_acid_leads_to_apoptosis_n_tumor_suppression_of_NPC.pdf
- 180_Recurrent_chemical_reactivations_of_EBV_promotes_genome_instability_n_enhances_tumor_progression_of_nasopharyngeal_carcinoma_cells.pdf
- 181_Identification_of_Novel_Small_Organic_Compounds_with_Diverse_Structures_for_the_Induction_of_EBV_Lytic_Cycle.pdf
- 182_Intracellular_Iron_Chelation_by_a_Novel_Compound_C7_Reactivates_EBV_Lytic_Cycle_via_the_ERK-Autophagy_Axis.pdf
- 183_Autophagy-Dependent_Reactivation_of_EBV_Lytic_Cycle_n_Combinatorial_Effects_of_Autophagy-Dependent_n_Independent_Lytic_Inducers.pdf
- 185_Targeting_EBV_in_Nasopharyngeal_Carcinoma.pdf
- 187_Therapeutic_Strategies_against_EBV-Associated_Cancers_Using_Proteasome_Inhibitors.pdf
- 188_TIPE1-mediated_autophagy_suppression_promotes_NPC_cell_proliferation_via_the_AMPK-mTOR_signalling_pathway.pdf
- 189_Contribution_of_EBV_Reactivation_to_the_Carcinogenicity_of_Nasopharyngeal_Cancer_Cell.pdf
- 190_Development_of_a_novel_inducer_for_EBV_lytic_therapy.pdf
- 191_The_PERK-Nrf2_Pathway_Mediates_Endoplasmic_Reticulum_Stres.pdf
- 192_The_NRF2-KEAP1_Pathway_Modulates_NPC_Cell_Radiosensitivity_via_ROS_Elimination.pdf
- 193_BDH2_triggers_ROS-induced_cell_death_n_autophagy_by_promoting_Nrf2_ubiquitination_in_gastric_cancer.pdf
- 194_Berbamine_induced_AMPK_activation_regulates_mTOR-SREBP-1c_axis_n_Nrf2-ARE_pathway_in_steatotic_HepG2_cells.pdf
- 195_Effects_of_a_novel_biflavonoid_of_Lonicera_japonica_flower_buds_on_modulating_apoptosis_in_hepatoma_cells.pdf
- 196_Lanthanum_chloride_induces_autophagy_in_rat_hippocampus_through_ROS-mediated_JNK_n_AKTmTOR_signaling_pathways.pdf
- 197_Neferine_prevents_NF-κB_translocation_n_protects_muscle_cells_from_oxidative_stress_n_apoptosis_induced_by_hypoxia.pdf
- 198_Neferine_prevents_autophagy_induced_by_hypoxia_through_activation_of_Akt-mTOR_pathway_n_Nrf2_in_muscle_cells.pdf
- 199_Scoparone_improves_hepatic_inflammation_n_autophagy_in_mice_with_nonalcoholic_steatohepatitis_macrophages.pdf
- 200_Synthetic_oleanane_triterpenoids-multifunctional_drugs_with_applications_for_prevention_n_treatment_of_chronic_disease.pdf
- 201_ROS-mediated_inactivation_of_the_PI3K-AKT_pathway_is_involved_in_the_antigastric_cancer_effects_of_chaetocin.pdf
- 202_Baicalein_enhanced_cisplatin_sensitivity_of_gastric_cancer_by_inducing_apoptosis_n_autophagy.pdf
- 204_mTORC2_facilitates_endothelial_cell_senescence_by_suppressing_Nrf2_expression_via_Akt-GSK-3β-C-EBPα_pathway.pdf
- 205_TORC2-SGK-1_signaling_integrates_external_signals_to_regulate_autophagic_turnover_of_mitochondria_via_mtROS.pdf
- 206_Activation_of_KGFR-Akt-mTOR-Nrf2_signaling_protects_human_retinal_pigment_epithelium_cells_from_Ultra-violet.pdf
- 207_PF-4708671_activates_Nrf2_by_promoting_p62-dependent_autophagic_degradation_of_Keap1.pdf
- 208_The_antioxidant_function_of_sestrins_is_mediated_by_promotion_of_autophagic_degradation_of_Keap1_n_Nrf2_activation.pdf
- 209_Regulation_of_mTORC2_Signaling.pdf
- 210_Research_progress_of_mTOR_inhibitors.pdf
- 211_Mitochondrial_Perturbations_Couple_mTORC2_to_Autophagy_in_C._elegans.pdf
- 212_mTORC2_controls_hydrophobic_motif_phosphorylation_n_activation_of_SGK1.pdf
- 213_Cellular_differentiation_regulator_BLIMP1_induces_EBV_lytic_reactivation_by_activating_transcription_R_n_Z_promoters.pdf
- 214_Differentiation-Dependent_LMP1_Expression_Is_Required_for_Efficient_Lytic_EBV_Reactivation_in_Epithelial_Cells.pdf
- 215_Inhibition_of_EBV_Replication_in_HPV-Immortalized_Keratinocytes.pdf
- 216_The_p65_Isoform_of_Nrf1_Is_a_Dominant_Negative_Inhibitor_of_ARE-mediated_Transcription.pdf
- 217_Activation_of_lytic_EBV_infection_by_radiation_n_NaB_for_treating_EBV-positive_malignancies.pdf
- 218_Azacitidine_induces_demethylation_of_the_EBV_genome_in_tumors.pdf
- 219_Bortezomib-induced_enzyme-targeted_radiation_therapy_in_herpesvirus-associated_tumors.pdf
- 221_Lytic_Induction_Therapy_against_EBV-Associated_Malignancies-Past_Present_n_Future.pdf
- 223_Viral-Targeted_Strategies_Against_EBV-Associated_Lymphoproliferative_Diseases.pdf
- 224_Curcuminoids_as_EBV_Lytic_Activators_for_Adjuvant_Treatment_in_EBV-Positive_Carcinomas.pdf
- 228_Targeting_EBV_LMP1-mediated_high_oxidative_stress_suppresses_EBV_lytic_reactivation_n_sensitizes_tumors_to_radiation_therapy.pdf
- 228_Targeting_EBV_LMP1-mediated_high_oxidative_stress_suppresses_EBV_lytic_reactivation_n_sensitizes_tumors_to_radiation_therapy_supp.pdf
- 229_Alterations_in_cellular_expression_in_EBV_infected_epithelial_cell_lines_n_tumors.pdf
- 230_CCAATEnhancer_Binding_Protein_α_Interacts_with_ZTA_n_Mediates_ZTA-Induced_p21CIP-1_Accumulation.pdf
- 231_Two_21-kilodalton_components_of_the_EBV_capsid_antigen_complex_n_their_relationship_to_ZEBRA-associated_protein_p21_ZAP21.pdf
- 232_Direct_Interaction_between_Nrf2_n_p21_Upregulates_the_Nrf2-Mediated_Antioxidant_Response.pdf
- 233_Functions_of_the_EBV_EBNA1_protein_in_viral_reactivation_n_lytic_infection.pdf
- 234_Proteomic_profiling_of_EBNA1-host_protein_interactions_in_latent_n_lytic_EBV_infections.pdf
- 235_EBNA1.pdf
- 236_EBV_EBNA1_Protein_Regulates_Viral_Latency_through_Effects_on_let-7_MicroRNA_n_Dicer.pdf
- 237_EBV-encoded_EBNA1_n_ZEBRA.pdf
- 238_LMP1_Is_a_Novel_Determinant_of_EBV_Genome_Persistence_n_Reactivation.pdf
- 239_Proteasomal_inhibition_triggers_viral_oncoprotein_degradation_via_autophagy-lysosomal_pathway.pdf
- 240_Carcinoma-risk_variant_of_EBNA1_deregulates_EBV_episomal_latency.pdf
- 241_Curcumin_Inhibits_Proliferation_of_EBV-Associated_Human_NPC_by_Inhibiting_EBV_EBNA1_Expression.pdf
- 242_In_Vivo_Dynamics_of_EBNA1-oriP_Interaction_during_Latent_n_Lytic_Replication_of_EBV.pdf
- 244_STUB1_is_targeted_by_the_SUMO-interacting_motif_of_EBNA1_to_maintain_EBV_latency.pdf
- 245_EBV_EBNA3A_Is_Critical_for_Maintaining_Lymphoblastoid_Cell_Line_Growth.pdf
- 246_EBV_BNA3C_is_required_for_cell_cycle_progression_n_growth_maintenance_of_lymphoblastoid_cells.pdf
- 247_Mechanisms_of_B-Cell_Oncogenesis_Induced_by_EBV.pdf
- 248_EBNA3B-deficient_EBV_promotes_B_cell_lymphomagenesis_in_humanized_mice_n_is_found_in_human_tumors.pdf
- 249_The_EBNA3_Family-Two_Oncoproteins_n_a_Tumour_Suppressor_that_Are_Central_to_the_Biology_of_EBV_in_B_Cells.pdf
- 250_LMP2_blocks_reactivation_of_EBV_from_latency_following_surface_immunoglobulin_crosslinking.pdf
- 251_LPM2_of_EBV_regulates_reactivation_from_latency_through_dominant_negative_effects_on_protein-tyrosine_kinases.pdf
- 252_LMP2B_regulates_susceptibility_to_induction_of_lytic_EBV_infection.pdf
- 253_Analysis_of_EBV_gene_expression_upon_phorbol_ester_n_hydroxyurea_treatment_by_real-time_quantitative_PCR.pdf
- 254_Effect_of_the_diterpene_ester_TPA_on_EBV_antigen-_n_DNA_synthesis_in_producer_n_nonproducer_cell_lines.pdf
- 255_Histone_Hyperacetylation_Occurs_on_Promoters_of_Lytic_Cycle_Regulatory_Genes_in_EBV-Infected_Cell_Lines.pdf
- 256_Suberoylanilide_hydroxamic_acid_induces_viral_lytic_cycle_in_EBV-positive_epithelial_malignancies_n_mediates_enhanced_cell_death.pdf
- 257_3H-1_2-dithiole-3-thione_protects_retinal_pigment_epithelium_cells_against_Ultra-violet_radiation_via_activation_of_Akt-mTORC1-dependent_Nrf2-HO-1_signaling.pdf
- 258_Endoplasmic_Reticulum_Stress-Mediated_Apoptosis_of_EBV-Transformed_B_Cells_by_Cross-Linking_of_CD70_Is_Dependent_upon_Generation_of_Reactive_Oxygen_Species_n_Activation_of_p38_MAPK_n_JNK_Pathway.pdf
- 259_A_Noncanonical_Basic_Motif_of_EBV_ZEBRA_Protein_Facilitates_Recognition_of_Methylated_DNA_HighAffinity_DNA_Binding_n_Lytic_Activation.pdf
- 259_Copy_number_of_EBV_latent_genome_correlates_with_the_oncogenicity_by_the_activation_level_of_LMP1_n_NF-κB.pdf
- 260_Bortezomib_induces_heme_oxygenase-1_expression_in_multiple_myeloma.pdf
- 260_Early_EBV_Genomic_Diversity_n_Convergence_toward_the_B95.8_Genome_in_Primary_Infection.pdf
- 261_Combined_inhibition_of_autophagy_n_Nrf2_signaling_augments_bortezomib-induced_apoptosis_by_increasing_ROS_production_n_ER_stress_in_pancreatic_cancer_cells.pdf
- 261_High_EBV_Load_n_Genomic_Diversity_Are_Associated_with_Generation_of_gp350-Specific_Neutralizing_Antibodies_following_Acute_Infectious_Mononucleosis.pdf
- 262_Degradation_of_p53_Can_Be_Targeted_by_HPV_E6_Sequences_Distinct_from_Those_Required_for_p53_Binding_n_Trans_Activation.pdf
- 262_HLA_alleles_modulate_EBV_viral_load_in_multiple_sclerosis.pdf
- 263_EBV_PCR_Sum.pdf
- 263_Rapid_determination_of_EBV_latent_or_lytic_infection_in_single_human_cells_using_in_situ_hybridization.pdf
- 264_Enzyme_immunoassays_for_the_diagnosis_of_EBV_infection.pdf
- 265_Oncogenic_Properties_of_the_EBV_ZEBRA_Protein.pdf
- 266_Sodium_butyrate_activates_NRF2_to_ameliorate_diabetic_nephropathy_possibly_via_inhibition_of_HDAC-J_Endocrinology.pdf
- 267_Sodium_butyrate_inhibits_high_cholesterol-induced_neuronal_amyloidogenesis_by_modulating_NRF2_stabilization-mediated_ROS_levels-involvement_of_NOX2_n_SOD1.pdf
Viral Load
- 101_Chaetocin_reactivates_the_lytic_replication_of_EBV_from_latency_via_reactive_oxygen_species.pdf
- 184_Pharmacologic_Activation_of_Lytic_EBV_Gene_Expression_without_Virion_Production.pdf
- 186_Inhibition_of_class_I_histone_deacetylases_by_romidepsin_potently_induces_EBV_lytic_cycle_ganciclovir.pdf
- 203_The_mTOR_Inhibitor_Manassantin_B_Reveals-A_Crucial_Role_of_mTORC2_Signaling_in_EBV_Reactivation.pdf
- 220_Emodin_Inhibits_EBV_Reactivation_and_Represses_NPC_Tumorigenesis.pdf
- 222_Rapamycin_enhances_lytic_replication_of_EBV_in_gastric_carcinoma_cells_by_increasing_the_transcriptional_of_lytic_promoters.pdf
- 225_Genipin_as_a_novel_chemical_activator_of_EBV_lytic_cycle.pdf
- 226_Cordycepin_is_a_novel_chemical_suppressor_of_EBV.pdf
- 227_Quercetin-induced_apoptosis_prevents_EBV_infection.pdf